NCT01335152

Brief Summary

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer. This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support. The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for phase_1 breast-cancer

Timeline
Completed

Started Apr 2010

Shorter than P25 for phase_1 breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 14, 2011

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

May 7, 2014

Status Verified

May 1, 2014

Enrollment Period

1 year

First QC Date

April 12, 2011

Last Update Submit

May 5, 2014

Conditions

Keywords

stressdepressionanxietywebinternetcoping

Outcome Measures

Primary Outcomes (3)

  • PHQ GAD-7 - Anxiety

    7-item self-report questionnaire measureing anxiety.

    baseline, post-intervention, follow-up

  • CES-D 10

    10 item self-report measure of depression.

    baseline, post-intervention, follow-up

  • FACT-B: Functional Assessment of Cancer Therapy - Breast

    44 item self-report measure of health related quality of life for breast cancer patients.

    baseline, post-intervention, follow-up

Secondary Outcomes (3)

  • Revised Impact of Event Scale

    baseline, post-intervention, follow-up

  • Benefit Finding Scale for breast cancer

    baseline, post-intervention, follow-up

  • CANCER BEHAVIOR INVENTORY (CBI-B)

    baseline, post-intervention, follow-up

Study Arms (2)

Web-based workbook

EXPERIMENTAL

Participants will use one chapter of the web-based workbook each week for 10 weeks. The workbook consists of stress management education, cognitive behavioral interventions and relaxation training exercises.

Behavioral: Coping with Breast Cancer web-based workbook

Waitlist control group

NO INTERVENTION

Participants will no intervention for the first 10 weeks of the study and then will receive the web-based intervention.

Interventions

10 chapter web-based workbook that teaches stress management, cognitive behavioral coping skills and relaxation training.

Also known as: Stress management, Coping with Cancer, Cancer Coping, Online workbook
Web-based workbook

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stage 0, I, II or III breast cancer within past 18 months
  • Elevated stress, distress or negative mood
  • Access at least 1.5 - 2 hours per week to a computer with audio capabilities that is connected to the internet
  • Ability to read, write, and speak English at a sixth grade level
  • Access to a telephone and an active e-mail account

You may not qualify if:

  • Cancer diagnosis is a recurrence
  • Diagnosis of schizophrenia
  • Use of anti-psychotic medication
  • Diagnosis of bipolar disorder without use of mood stabilizing medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Talaria, Inc

Seattle, Washington, 98122, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsDepressionAnxiety Disorders

Interventions

Coping Skills

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Kelly M Carpenter, PhD

    Talaria, Inc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2011

First Posted

April 14, 2011

Study Start

April 1, 2010

Primary Completion

April 1, 2011

Study Completion

August 1, 2011

Last Updated

May 7, 2014

Record last verified: 2014-05

Locations